Hutchinson Technology Inc.
The non-invasive InSpectra™ StO2 Tissue Oxygenation Monitor provides continuous, real-time information for perfusion status monitoring; a new hemodynamic parameter that assists clinicians in the early detection of inadequate tissue perfusion (hypoperfusion). The InSpectra StO2 System provides value to clinicians by allowing them to track patient response (regardless of the cause of hypoperfusion (e.g. hypovolemia, early sepsis, cardiogenic shock) to interventions in real-time, assisting with fluid management.
40 West Highland Park Drive NE